| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Meakins-Christie Laboratories, Montreal Chest Institute, McGill University Hospital Centre, and 2 Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, QC, Canada.
CORRESPONDENCE: M. S. Ludwig, Meakins-Christie Laboratories, 3626 St. Urbain Street, Montreal, QC, H2X 2P2, Canada. Fax: 1 5143987483. E-mail: mara.ludwig{at}mcgill.ca
Keywords: Airway smooth muscle, biglycan, decorin, lumican, versican
Received: April 20, 2005
Accepted August 24, 2006
Excess deposition of proteoglycans (PGs) has been described in the subepithelial layer of the asthmatic airway wall. However, less is known about deposition in the airway smooth muscle (ASM) layer, and whether the pattern of deposition is altered depending upon disease severity.
Endobronchial biopsies were performed in patients with severe or moderate asthma (defined using American Thoracic Society criteria) and in control subjects. Biopsies were immunostained for the PGs biglycan, lumican, versican and decorin. PG deposition was measured in the subepithelial and ASM layers, the former by calculating the area of positive staining, and the latter by determining the percentage area stained using point counting.
Immunostaining for PGs was prominent in biopsies from both moderate and severe asthmatics, compared with control subjects. While there was no difference in the amount of PG in the subepithelial layer between the two asthmatic groups, the percentage area of biglycan and lumican staining in the ASM layer was significantly greater in moderate versus severe asthmatics.
Differences in the deposition of proteoglycans within the airway smooth muscle layer of moderate versus severe asthmatics potentially impact on the functional behaviour of the airway smooth muscle in these two groups of patients.
This article has been cited by other articles:
|
|
 |
|
  S. Siddiqui, F. Hollins, and C. E. Brightling What can we learn about airway smooth muscle from the company it keeps? Eur. Respir. J., July 1, 2008; 32(1): 9 - 11. [Full Text] [PDF]
|
|
|
|
|
|
B. B. Araujo, M. Dolhnikoff, L. F. F. Silva, J. Elliot, J. H. N. Lindeman, D. S. Ferreira, A. Mulder, H. A. P. Gomes, S. M. Fernezlian, A. James, et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma Eur. Respir. J., July 1, 2008; 32(1): 61 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. D'Antoni, C. Torregiani, P. Ferraro, M.-C. Michoud, B. Mazer, J. G. Martin, and M. S. Ludwig Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L764 - L771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Salerno, V. Pinelli, L. Pini, B. Tuma, R. V. Iozzo, and M. S. Ludwig Effect of PEEP on induced constriction is enhanced in decorin-deficient mice Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1111 - L1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Ludwig Proteoglycans and pathophysiology J Appl Physiol, September 1, 2007; 103(3): 735 - 736. [Full Text] [PDF]
|
|
|
|
|
|
S. S. An, T. R. Bai, J. H. T. Bates, J. L. Black, R. H. Brown, V. Brusasco, P. Chitano, L. Deng, M. Dowell, D. H. Eidelman, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma Eur. Respir. J., May 1, 2007; 29(5): 834 - 860. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
